Original articleMelanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
Section snippets
Data sources
The Cancer Registry of Norway (CRN) has recorded all cancer diagnoses nationwide since 1953. The Norwegian Malignant Melanoma Registry (NMMR) was established under the CRN in 2008, adding Breslow thickness and other histopathologic and clinical information to each CM case. We included all patients with a morphologically verified first primary invasive CM in Norway between 2008 and 2015 and with Breslow thickness recorded in the NMMR.
Extracting data from cancer-specific registries and working
Results
Between 2008 and 2015, 13,386 Norwegians were diagnosed with a morphologically verified first primary invasive CM. The mean age at diagnosis was 62.8 years of age (range, 2-98 years of age). Breslow thickness was recorded for 13,057 (97.5%) of these patients (6470 men and 6587 women) with a median of 1.0 mm (range, 0.09-85 mm). Thickness was reported to 1 decimal place for 10,211 of the patients (78.2%; range, 0.1-25.5 mm) but also as whole numbers (n = 2032, 15.6%; range, 1-85 mm) and with 2
Discussion
In this national study of Breslow thickness data, thin tumors were reported with more precision than thicker tumors. Reporting of thickness to the nearest 0.1-mm increased by calendar year. Terminal digit clustering was found with marked peaks in the observed frequency distribution for terminal digits 0 and 5, and with drops around these peaks. Smoothing of the observed Breslow thickness distribution demonstrated that terminal digit clustering increased proportions of tumors classified as T1
References (29)
- et al.
Diagnosis and treatment of melanoma. European consensus-based interdiciplenary guideline – update 2016
Eur J Cancer
(2016) - et al.
Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992–2013
J Am Acad Dermatol
(2017) - et al.
Effect of terminal digit preference on blood pressure measurement and treatment in primary care
Am J Hypertens
(2006) - et al.
Density estimation for data with rounding errors
Comp Statist Data Anal
(2013) - et al.
Terminal digit preference, random error, and bias in routine clinical measurement of blood pressure
J Clin Epidemiol
(1993) - et al.
Observer error and birthweight: digit preference in recording
Public Health
(1997) - et al.
Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness
Eur J Cancer
(2009) - et al.
The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008
Cancer Epidemiol
(2013) - et al.
Data set for pathology reporting of cutaneous invasive melanoma. Recommendations from the International Collaboration of Cancer Reporting (ICCR)
Am J Surg Pathol
(2013) - et al.
Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eight edition cancer staging manual
CA Cancer J Clin
(2017)
Breslow thickness measurements of melanoma around American Joint Committee of Cancer staging cut-off points: imprecision and terminal digit bias have important implications for staging and patient management
Ann Surg Oncol
Does terminal digit preference occur in pathology?
J Clin Pathol
Terminal digit preference biases polyp size measurements at endoscopy, computed tomographic colonography, and histopathology
Endoscopy
Rounding of birth weights in a neonatal intensive care unit over 20 years: an analysis of a large cohort study
BMJ Open
Cited by (6)
Nevus Count, Pigmentary Characteristics, and Melanoma-specific Mortality among Norwegian Women with Melanoma >1.0 mm Thick
2023, Acta Dermato-VenereologicaSlow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients
2021, Dermatologic SurgeryRisk of Melanoma Recurrence after Diagnosis of a High-Risk Primary Tumor
2019, JAMA Dermatology
Funding sources: None.
Conflicts of interest: None disclosed.
Presented as a poster at the World Conference of Melanoma, Brisbane, Australia, October 18-21, 2017.
Reprints not available from the authors.